Waltham, Massachusetts-based Alere acquired wireless remote patient monitoring company MedApps last month for an undisclosed sum, MobiHealthNews has learned. MedApps CEO Kent Dicks confirmed the news in an email to MobiHealthNews this afternoon.
MedApps offers a suite of home health devices, including the HealthPAL, a small, portable, dedicated device that the company used to collect data from connected glucose meters, blood pressure monitors, pulse oximeters and weight scales. The data is then sent over a secure server to an online portal for caregivers, physicians or the patient themselves to view. The FDA granted HealthPAL 510(k) clearance about three years ago and a CE Mark in early 2010.
While more details about the acquisition are likely to emerge when the deal is officially announced (perhaps as early as next week), the MedApps deal is part of a larger strategy that likely builds on Alere’s announcement last week about its deal with AT&T to integrate WellDoc’s DiabetesManager mobile application and service into its offerings.
MedApps has inked deals with VRI, AT&T, CardioNet, and others over the years. The company has piloted HealthPAL at The Cleveland Clinic, Baptist Home Health Network, and New Jersey’s Meridian Health.
Alere already has distribution deals with AirStrip Technologies and Monica Healthcare for remote fetal monitoring technologies. The company also has an exclusive deal with Voxiva to offer that company’s Text2Quit smoking cessation service in the United States.